Lexicon Pharmaceuticals, Inc. ( LXRX ) was a big mover last session with its shares rising nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost almost 4% in the past one-month time frame.
This biotechnology company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Lexicon currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Investors interested in the biomedical industry may also consider stocks like Actelion Ltd. ( ALIOF ), Biogen Idec Inc. ( BIIB ) and Osiris Therapeutics, Inc. ( OSIR ). All the three stocks sport a Zacks Rank #1 (Strong Buy).